Platelet zinc status regulates prostaglandin-induced signaling, altering thrombus formation
Journal of Thrombosis and Haemostasis · 2023-09 · 21 (9) · 2545-2558
DOI: 10.1016/j.jtha.2023.05.008 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Thrombosis and Haemostasis, 2023-09. Verfasst von Charlie A Coupland und 9 weiteren Autor:innen. Beteiligte Einrichtung: Centre for Biomedicine, Hull York Medical School, University of Hull, Hull, UK. Hauptthemen laut MEDLINE: Blood Platelets, Thrombosis. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: British Heart Foundation, Medical Research Council.
Abstract (Originalsprache)
BACKGROUND: Approximately 17.3% of the global population exhibits an element of zinc (Zn2+) deficiency. One symptom of Zn2+ deficiency is increased bleeding through impaired hemostasis. Platelets are crucial to hemostasis and are inhibited by endothelial-derived prostacyclin (prostaglandin I2 [PGI2]), which signals via adenylyl cyclase (AC) and cyclic adenosine monophosphate signaling. In other cell types, Zn2+ modulates cyclic adenosine monophosphate concentrations by changing AC and/or phosphodiesterase activity. OBJECTIVES: To investigate if Zn2+ can modulate platelet PGI2 signaling. METHODS: Platelet aggregation, spreading, and western blotting assays with Zn2+ chelators and cyclic nucleotide elevating agents were performed in washed platelets and platelet-rich plasma conditions. In vitro thrombus formation with various Zn2+ chelators and PGI2 was assessed in whole blood. RESULTS: Incubation of whole blood or washed platelets with Zn2+ chelators caused either embolization of preformed thrombi or reversal of platelet spreading, respectively. To understand this effect, we analyzed resting platelets and identified that incubation with Zn2+ chelators elevated pVASPser157, a marker of PGI2 signaling. In agreement that Zn2+ affects PGI2 signaling, addition of the AC inhibitor SQ22536 blocked Zn2+ chelation-induced platelet spreading reversal, while addition of Zn2+ blocked PGI2-mediated platelet reversal. Moreover, Zn2+ specifically blocked forskolin-mediated AC reversal of platelet spreading. Finally, PGI2 inhibition of platelet aggregation and in vitro thrombus formation was potentiated in the presence of low doses of Zn2+ chelators, increasing its effectiveness in inducing platelet inhibition. CONCLUSION: Zn2+ chelation potentiates platelet PGI2 signaling, elevating PGI2's ability to prevent effective platelet activation, aggregation, and thrombus formation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Centre for Biomedicine, Hull York Medical School, University of Hull, Hull, UK.
- Department of Imaging Chemistry and Biology, School of Biomedical Engineering and Imaging Sciences, King's College London, London, UK.
- Centre for Biomedicine, Hull York Medical School, University of Hull, Hull, UK. Electronic address: simon.calaminus@hyms.ac.uk.
Förderung
- British Heart Foundation
- Medical Research Council
Zitieren
APA
Coupland, C. A., Naylor-Adamson, L., Booth, Z., Price, T. W., Gil, H. M., Firth, G., Avery, M., Ahmed, Y., Stasiuk, G. J., & Calaminus, S. D. J. (2023). Platelet zinc status regulates prostaglandin-induced signaling, altering thrombus formation. Journal of Thrombosis and Haemostasis, 21(9), 2545-2558. https://doi.org/10.1016/j.jtha.2023.05.008
Vancouver
Coupland CA, Naylor-Adamson L, Booth Z, Price TW, Gil HM, Firth G, et al. Platelet zinc status regulates prostaglandin-induced signaling, altering thrombus formation. Journal of Thrombosis and Haemostasis. 2023;21(9):2545-2558. doi:10.1016/j.jtha.2023.05.008
BibTeX
@article{Coupland2023,
author = {Coupland, Charlie A and Naylor-Adamson, Leigh and Booth, Zoe and Price, Thomas W and Gil, Helio M and Firth, George and Avery, Michelle and Ahmed, Yusra and Stasiuk, Graeme J and Calaminus, Simon D J},
title = {Platelet zinc status regulates prostaglandin-induced signaling, altering thrombus formation},
journal = {Journal of Thrombosis and Haemostasis},
year = {2023},
volume = {21},
number = {9},
pages = {2545--2558},
doi = {10.1016/j.jtha.2023.05.008}
}
EUVIMED